Recent studies highlight regional variations in Curcuma kwangsiensis radix’s anti-thrombotic properties, with blockchain technology emerging as a solution for quality control and supply chain in...
New research shows significant regional differences in bioactive compounds of Curcumae kwangsiensis radix, with Guangxi varieties showing superior cardiovascular benefits. Cutting-edge studies reveal ...
New research reveals Guangxi-sourced CKR has 15% higher curcumin content than Yunnan’s, with distinct pharmacological effects on thrombosis through spectrum-effect relationship analysis. Groundb...
